Edvar Onsoyen
Sandvika, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
OligoG CF-5/20 normalizes cystic fibrosis mucus by chelating calcium.
Journal: Clinical and experimental pharmacology & physiology
Published: November 23, 2016
A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease.
Journal: Molecular pharmaceutics
Published: February 03, 2016
A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 28, 2016
OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.
OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: July 14, 2015
Alginate oligosaccharides inhibit fungal cell growth and potentiate the activity of antifungals against Candida and Aspergillus spp.
Journal: PloS one
Published: May 12, 2014
A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa.
Journal: American journal of respiratory cell and molecular biology
Published: October 01, 2013
An in vitro study of alginate oligomer therapies on oral biofilms.
Journal: Journal of dentistry
Published: May 03, 2013
The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms.
Journal: Biofouling
Published: April 12, 2013
Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.
Journal: Antimicrobial agents and chemotherapy
Published: July 25, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026